{
    "N/R/U": null,
    "Applicant": "Novo Nordisk Inc.",
    "BLA Number": "19991",
    "Proprietary Name": "Novolin 70/30",
    "Proper Name": "insulin isophane human and insulin human",
    "BLA Type": "351(a)",
    "Strength": "90UNITS/3ML (30UNITS/ML); 210UNITS/3ML (70UNITS/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Autoinjector",
    "Marketing Status": "OTC",
    "Licensure": "Licensed",
    "Approval Date": "1-Jun-18",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "79",
    "Submission Type": "Supplement",
    "License Number": "1261",
    "Product Number": "2",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "insulin isophane human and insulin human"
        }
    ]
}